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To understand the interactions between substance P and
gut inflammation, changes in substance P levels were
evaluated in a chronic model of ileitis in response to three
anti-inflammatory agents with distinct mechanisms of
action. The agents were the prostaglandin Et analogue
misoprostol (30 #g/kg, s.c., b.i.d.), the nitric oxide syn-
thase inhibitor NG-nitro-L-arginine methyl ester (L-
NAME, 100 #g/ml in drinking water) and the leumedin,
N-(fluorenyl-9-methoxycarbonyl)-L-leucine (NPC 15199,
10mg/kg, s.c.). Ileitis was induced by a transmural
injection of trinitrobenzene sulphonic acid (TNBS
30mg/kg in 50% ethanol) into the distal ileum of
guinea-pigs. All anti-inflammatory therapies were in-
troduced after TNBS administration and continued until
day 7, when guinea-pigs were killed. Ileal substance P
levels were measured by radioimmunoassay, and granulo-
cyte infiltration was quantified by myeloperoxidase (MPO)
activity. Protein and nitrite (an index of nitric oxide
formation) levels in a luminal saline lavage were
quantified in all groups. TNBS ileitis caused a marked
reduction in ileal substance P content and increased MPO
activity, protein and nitrite secretion. The nitric oxide
synthase inhibitor, L-NAME, completely restored all
parameters to baseline, iisoprostol attenuated the
granulocyte infiltration and exacerbated protein leak but
had no effect on substance P levels. In contrast, NPC 15199
had no effect on granulocyte infiltration but normalized
substance P levels and protein leak. Only L-NAME and
NPC 15199 blocked the TNBS induced increase in nitrite
levels. These results suggest that the regulation of
granulocyte infiltration in this model is unrelated to
changes in substance P levels. Inhibition of nitric oxide
synthase was the most effective therapeutic strategy in
TNBS ileitis but the precise interactions between nitric
oxide and the enteric nervous system during inflammatory
states remain to be defined.
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Introduction
A model of chemical ileitis, induced by intra-
luminal trinitrobenzene sulphonic acid (TNBS) in a
50% ethanol solution has been developed. 1’2 This
model is an adaptation of the TNBS colitis model
used by several groups. 3’4 TNBS ileitis is associated
with a marked granulocyte and mononuclear infil-
tration, submucosal fibrosis, crypt, smooth muscle
and mast cell hyperplasia, protein and fluid
secretion. These responses peak around 7 days post-
TNBS, with a gradual restoration of structure and
function within 1 month. 1’2 Although clearly an
artificial means of inducing subchronic inflamma-
tion, this model does bear a resemblance to Crohn’s
disease.
Because inflammation is induced in the guinea-
pig ileum, there is the opportunity to evaluate
(C) 1993 Rapid Communications of Oxford Ltd
interactions between substance P and the infl-
ammatory processes, as substance P innervation has
been extensively characterized in the guinea-pig
ileum, It has recently been shown that in TNBS
ileitis there is a sustained loss of intestinal substance
P content which parallels the time-course of the
other indices of ileitis. This reduction in substance
P was confined to the mucosa/submucosa and in
particular, perivascular innervation.
6 Peptide neuro-
transmitters including CGRP, VIP, and substance
P, have been evaluated in models of gut
inflammation and clinical specimens, but a con-
sensus as to how these neurotransmitters participate
in or respond to the inflammatory process, has not
been reached. 7-9
In order to examine how the changes in substance
P levels in ileitis, the effects of three anti-
inflammatory agents which differ markedly in
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structure and mechanism of action were compared.
The anti-inflammatory agents chosen were mis-
oprostol, a PGE1 analogue with various cytopro-
tective properties ;10,11 the leumedin, NPC 15199,
which has diverse anti-inflammatory and immuno-
suppressive actions;12’13 and L-NAME, a non-
specific inhibitor of nitric oxide synthase.
TM Under
acute circumstances, inhibition of nitric oxide
formation exacerbates granulocyte infiltration and
inflammation.s However, it has been noted that in
the TNBS model of ileitis, nitric oxide synthase
inhibition ameliorated the inflammation. Thus,
nitric oxide synthase inhibitors can display both
pro- and anti-inflammatory properties, depending
on the duration of administration and pathophysio-
logy and possibly the enzyme source of nitric
oxide. 1’15 The aim of the study was to identify
components of the inflammatory process which
interact with the enteric nervous system and
influence substance P dependent mechanisms.
Materials and Methods
TNBS ileitis: The characteristics of this model in
guinea-pigs have recently been described. 1’2’6 Under
aseptic surgical conditions fasted female Hartley
guinea-pigs (250-350 g) were anaesthetized with
ketamine (40 mg/kg) and the distal ileum isolated
after a midline laparotomy. TNBS (30 mg/kg in
50% ethanol) was injected into the lumen of ileum
by transmural injection using a 26 gauge needle.
Control animals received an equivalent volume of
saline (sham) or 50% ethanol (vehicle). The
abdominal incision was sutured and the guinea-pig
was transferred to a heated waterbed for post-
operative recovery. Guinea-pigs were anaesthetized
7 days later as described above. The distal ileum
was ligated into a loop, commencing 15 cm from
the ileocaecal valve, 2 ml of saline was injected
intraluminally and after 30 min the loop fluid was
removed. Loop fluid volume was recorded, the fluid
was centrifuged to remove particulate matter, and
the supernatant divided into aliquots and frozen.
Sections of ileum were used for estimation ofMPO
activity and SP content.
Misoprostol was administered subcutaneously,
twice daily (30 mg/kg, s.c., b.i.d.) for 7 days, the
first dose was given 20min before ileitis induction.
L-NAME was administered in the drinking water
(100#g/ml ad libitum) and NPC 15199 was
administered by subcutaneous injection (10 mg/kg)
daily for 7 days.
Substance P content: Approximately 1 g of tissue from
each loop was separated, chopped, weighed and
then boiled in 5 ml/g of tissue wet weight of
0.1 N HC1 for 10 min. The tissue was then sonicated
and centrifuged at 1 300 x g for 10min. The
supernatant was collected, coded and frozen at
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-70C until levels of substance P were measured
by radioimmunoassay (RIA). The pH of super-
natants was normalized (pH 7.0) prior to RIA,
which was conducted without knowledge of the
experimental protocol.
Substance P and substance P antiserum were
obtained from Cambridge Research Biochemicals
(Valley Stream, NY). 2SI-labelled SP was purchased
from New England Nuclear (Boston, MA). Goat
anti-rabbit gamma-globulin antibodies and normal
rabbit serum were from Calbiochem (LaJolla, CA).
The substance P RIA was carried out at room
temperature as described previously,
a6 Briefly,
samples were diluted in 300 #1 of RIA buffer (0.2%
BSA, 0.1% Triton X-100, and 0.02% NaN3 in PBS)
and mixed with 100/.tl each of 1"200 diluted
substance P antiserum and 25I-labelled substance P
(10 000 cpm/tube). After 2 h incubation, 100 1 each
of the goat anti-rabbit gamma-globulin antibodies
and the normal rabbit serum were added and
incubated further for 45 min. The antigen-antibody
complex was then precipitated with 1 ml of 17.5%
polyethylene glycol and centrifuged in a tabletop
centrifuge. The supernatant was decanted and the
radioactivity in the pellet was counted in a gamma
counter. The total binding and nonspecific binding
were measured in the absence of nonradioactive
substance P and substance P antiserum, respec-
tively. In general, the radioactivities measured in
the total and nonspecific binding were 6 000 and
300 cpm, respectively.
Myeloperoxidase activity: Intestinal tissue (100-250 mg)
was finely minced at 4C and homogenized with a
Brinkman polytron for 20 s in 50 mM hexadecyl-
trimethylammonium bromide to negate the pseudo-
peroxidase activity of haemoglobin. The homo-
genate was centrifuged at 20 000 x g for 15 min.
The pellet was frozen and thawed. This cycle of
homogenization and freeze/thawing was repeated
twice. An extract of the final supernatant (100/1)
was mixed with 2.9 ml of potassium phosphate
buffer (50 mM, pH 6.0) containing 0.167 mg/ml of
O-dianisidine dihydrochloride and 0.0005% of
hydrogen peroxide. Absorbance at 460nm was
determined on a Beckman DU-64 spectrophoto-
meter over 3 min. One unit of myeloperoxidase
activity was defined as that required to degrade
1/mol of H202 per minute at 25C. This method
has been previously described for this model. 1’2’6
Ileal lavage anasis: Fluid removed from 30 min saline
lavages was analysed for protein content with a
spectrophotometric method as described previous-
ly. 1’2’6 Loop fluid nitrite levels were used as an index
of nitric oxide production. Nitrite levels were
quantified with the Griess reaction as described
previously. ’2’6 Both lavage protein and nitrite levels
were normalized for loop weight.Granulotes, nitric oxide and substance P
Results 8O
Myeloperoxidase activity: One week after TNBS
administration ileal MPO activity was markedly
elevated above sham-operated controls (Fig. 1).
Concomitant treatment with misoprostol attenuated
granulocyte infiltration whereas L-NAME abo-
lished the response, i.e. MPO levels were equivalent
to the basal values found in sham-operated controls.
In contrast, NPC 15199 did not affect TNBS
induced increases in ileal MPO activity (Fig. 1). The
authors noted that higher concentrations of NPC
15199 (100mg/kg s.c.) prevented the increased
MPO activity following TNBS. However, these
results were not detailed in this study. Thus, the
observations with NPC 15199 are consistent with
published reports on its ability to inhibit
neutrophil-endothelium interactions. 12’13 The high
dose ofNPC 15199 also restored substance P levels
(data not shown).
Substance P content: Whole intestinal substance P
content is reduced by approximately 40% at day 7
of TNBS treated animals (Fig. 2). Misoprostol
administration had no effect on TNBS induced
reductions in substance P content. However, both
L-NAME and NPC 15199 restored substance P
levels to those found in sham controls (Fig. 2).
Ileal lavage protein and nitrite levels: TNBS ileitis was
associated with a marked increase in lavage protein
levels (Fig. 3). This response was exacerbated by
misoprostol (p < 0.05) but completely abolished by
either L-NAME or NPC 15199 (p < 0.02).
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FIG. 1. Granulocyte infiltration into the ileum as determined by
myeloperoxidase activity (units/100 rag) in sham operated controls,
TNBS induced ileitis and TNBS with concomitant therapy with
misoprostol (30mg/kg, s.c., b.i.d.), L-NAME (100#g/ml in drinking
water, adlibiturn) or NPC 15199 (10 mg/kg, s.c.). All groups were treated
for 7 days. Significant difference from control (sham) animals
(p < 0.05). Significant difference between TNBS alone vs. TNBS with
drug therapy (p < 0.05). I-I, Control;., TNBS; I1, TNBS + MISO; 12],
TNBS + L-NAME; I, TNBS+NPC 15199.
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FIG. 2. Substance P content (pmol/g) in whole ileal segments determined
by radioimmunoassay, in sham operated controls, TNBS induced ileitis
and TNBS with concomitant therapy with misoprostol (30 mg/kg, s.c.,
b.i.d.), L-NAME (100 #g/ml in drinking water, ad libitum) or NPC 15199
(10 mg/kg, s.c.). All groups were treated for 7 days. Significant difference
from control (sham) animals (p < 0.05). Significant difference
between TNBS treatment alone vs. TNBS with drug therapy (p < 0.05).
I-], Control; ,, TNBS; I1, TNBS + MISO; 12], TNBS + L-NAME; I,
TNBS+ NPC 15199.
Lavage nitrite levels were also elevated above
baseline in TNBS ileitis (p < 0.05). This response
was unaltered by misoprostol treatment but
completely prevented by either L-NAME or NPC
15199 administration (p < 0.05, Fig. 4). Table 1
summarizes the markers of gut inflammation and
the influence of the therapeutic approaches.
Morphologically, only L-NAME restored normal
gut appearance; in either NPC 15199 or misoprostol
treated animals the crypt hypertrophy, submucosal
fibrosis and smooth muscle hyperplasia that are
associated with TNBS ileitis were readily apparent.
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FIG. 3. Ileal lavage protein levels (/tg/g) in sham operated controls, TNBS
induced ileitis and TNBS with concomitant therapy with misoprostol
(30mg/kg, s.c., b.i.d.), L-NAME (100#g/ml in drinking water, ad
libitum) or NPC 15199 910 mg/kg, s.c.). All groups were treated for 7
days. Significant difference from control (sham) animals (p < 0.05).
Significant difference between TNBS alone vs. TNBS with drug
therapy (p< 0.05). I--I, Control; , TNBS’ , TNBS + MISO; 171,
TNBS + L-NAM E" I1, TNBS+ NPC 15199.
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FIG. 4. Ileal lavage nitrite levels (rig/g) in s.ham operated controls, TNBS
induced ileitis and TNBS with concomitant therapy with misoprostol
(30mg/kg, s.c., b.i.d.), L-NAME (100#g/ml in drinking water, ad
libitum) or NPC 15199 (10 mg/kg, s.c.). All groups were treated for 7
days. Significant difference from control (sham) animals (p < 0.05).
Significant difference between TNBS alone vs. TNBS with drug
therapy (p< 0.05). I-I, Control; B, TNBS; I1., TNBS + MISO; I’FI,
TNBS + L-NAME; I, TNBS+NPC 15199.
Table 1. Indices of ileitis and the influence of anti-inflammatory
agents
Treatment group Change from control animals
Lavage Lavage
MPO SP protein nitrite
TNBS 1’1’ 1’ 1’
TNBS and misoprostol 1" $ TT T
TNBS and L-NAME
TNBS and NPC 15199 1’1’
Arrows indicate the direction of change, the number of arrows
indicate the magnitude of an alteration from control guinea-pigs.
Discussion
One week after induction of ileitis with TNBS
intestinal substance P content was markedly
reduced. This primarily reflects alterations in
submucosal substance P and to a lesser extent
mucosal sites, because it has been .noted previously
that rnyenteric plexus substance P content remains
unaltered.
6 The present study was designed to
determine the relationship between these changes
in ileal substance P and the inflammatory process,
through the use of three structurally and
mechanistically different non-steroidal anti-inflam-
matory agents.
Perhaps the most intriguing finding was that the
degree of granulocyte infiltration was unrelated to
the reductions in substance P content. This finding
was revealed by comparing the effects of mis-
oprostol and NPC 15199. Misoprostol attenuated
ileal MPO levels but had no effect on the substance
P response, whereas NPC 15199 had no effect on
MPO levels but normalized ileal substance P levels.
The nitric oxide synthase inhibitor, L-NAME,
corrected both MPO and substance P, which is an
important observation but does not reveal a specific
relationship between granulocyte infiltration and
substance P.
From these observations, it is concluded that
granulocytes are unlikely to mediate the changes in
substance P content. This assumes that changes in
MPO activity reflect granulocyte infiltration in the
gut. This assumption is generally accepted although
other cell types, such as macrophages, do contain
myeloperoxidase. This conclusion does not pre-
clude other interactions between sensory neuropep-
tides and granulocytes. For example granulocyte
derived oxidants can degrade substance p17 and
inhibit its degradation by neutral endopeptidase
24.11.18 In addition, substance P can promote
granulocyte adherence to vascular endothelium.
19
However, changes in substance P content, which
primarily reflects the balance of neuronal substance
P synthesis and release, appear to be regulated by
factors other than granulocytes.
The nature of these factors remains unknown.
However, one possibility is nitric oxide. The nitric
oxide synthase inhibitor, L-NAME, restored
substance P levels and all other indices of gut
injury. Luminal nitrite levels, which is an in vivo
index of nitric oxide production, were also
normalized by NPC 15199. This experimental
leumedin was as effective as L-NAME in restoring
substance P content. It is possible that their effects
on substance P were mediated by a common
mechanism, possibly inhibition of nitric oxide
synthase. However, NPC 15199 appears to have
numerous immunosuppressive and anti-inflamma-
tory properties which could be important, particu-
larly as intestinal substance P is known to be linked
to the gut associated lymphoid tissue.2 Neverthe-
less if nitric oxide is an important regulator of
neuronal substance P, its source is unlikely to be
granulocyte derived.
21 Nitric oxide has numerous
anti-inflammatory properties, such as inhibition of
granulocyte-endothelial interactions
is and im-
proved epithelial barrier function,2’22 which are
readily demonstrable under acute conditions.
However, in chronic inflammatory states, it appears
that nitric oxide is pro-inflammatory, probably via
free radical mechanisms and the induction of the
inducible form of nitric oxide synthase. Whether
neuronal (NOS III) or immune/inducible (NOS II)
nitric oxide synthase is the source of nitric oxide
for these effects is unknown. Immunohistochemical
localization of submucosal substance P is anatomic-
ally similar to sites of constitutive NOS activity
(NOS I and III),
23 particularly perivascular
innervation in guinea-pig intestine. On the other
hand TNBS ileitis is associated with induction of
the NOS II form of nitric oxide synthase,
24 a form
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of nitric oxide synthase is usually quiescent in the
gut.
is The injurious effects of nitric oxide are usually
linked to the inducible form because it has the
capacity to produce large amounts of nitric oxide,
approximately three orders of magnitude greater
than the constitutive forms of nitric oxide
synthase.
13 Large amounts of nitric oxide, acting
alone as a free radical, or in concert with other free
radical species implicated in gut inflammation,
26
appears to be important in the pathogenesis of this
model of inflammatory bowel disease, as L-NAME
was clearly the superior therapeutic agent used in
this model. This dose of L-NAME does cause a
modest rise in blood pressure in guinea-pigs, but
splanchnic blood flow was not significantly
altered,
27 as would be expected. Organ blood flow
is not compromised in hypertensive states, blood
pressure is raised to maintain adequate organ
perfusion when vascular tone is altered.
Although substance P and many other enteric
neuropeptides influence mucosal function, the
authors could not decipher the precise role of
substance P in this model. The availability of
non-peptide substance P antagonists for chronic
models of inflammation will be invaluable. Until
then studies primarily describe observations and not
causations. Nevertheless, our determination that the
changes in substance P content in chronic ileitis
were granulocyte independent provides some
insight. The possibility that nitric oxide may play a
role is intriguing, but clearly further investigation
is needed in order to unravel these complex
interactions.
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